Ignite Creation Date:
2024-06-16 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06423326
Status:
RECRUITING
Last Update Posted:
2024-05-21
First Post:
2024-04-10
Brief Title:
Gemcitabine Cisplatin and Nab-Paclitaxel As Neoadjuvant Treatment for Patients with Resectable or Borderline Resectable Pancreatic Cancer
Sponsor:
Emory University
Organization:
Emory University
Organization Data
Organization:
Emory University
Class:
OTHER
Study ID:
STUDY00006976
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Emory University
Lead Sponsor Class:
OTHER
Responsible Party:
Mihir M Shah MD FACS FSSO
Responsible Party Title:
Principal Investigator
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Emory University
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |